-
1
-
-
0030783036
-
A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol
-
Anderson S.D., Brannan J., Spring J., Spalding N., Rodwell L.T., Chan H.-K., Gonda I., Walsh A., and Clark A.R. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am. J. Respir. Crit. Care Med. 156 (1997) 758-765
-
(1997)
Am. J. Respir. Crit. Care Med.
, vol.156
, pp. 758-765
-
-
Anderson, S.D.1
Brannan, J.2
Spring, J.3
Spalding, N.4
Rodwell, L.T.5
Chan, H.-K.6
Gonda, I.7
Walsh, A.8
Clark, A.R.9
-
2
-
-
0036804025
-
Deposition and pharmacokinetics of budesonide from the Miat monodose inhaler, a simple dry powder device
-
Ball D., Hirst P., Newman S., Bernard S., Streel B., and Vanderbist F. Deposition and pharmacokinetics of budesonide from the Miat monodose inhaler, a simple dry powder device. Int. J. Pharm. 245 (2002) 123-132
-
(2002)
Int. J. Pharm.
, vol.245
, pp. 123-132
-
-
Ball, D.1
Hirst, P.2
Newman, S.3
Bernard, S.4
Streel, B.5
Vanderbist, F.6
-
3
-
-
28844485771
-
The safety and efficacy of inhaled dry powder mannitol as a bronchial provacation test for airway hyperresponsiveness: a phase 3 comparision study with hypertonic (4.5%) saline
-
Brannan J., Anderson S.D., Perry C.P., Freed-Martens R., Lassig A.R., and Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provacation test for airway hyperresponsiveness: a phase 3 comparision study with hypertonic (4.5%) saline. Respir. Res. 6 (2005) 144
-
(2005)
Respir. Res.
, vol.6
, pp. 144
-
-
Brannan, J.1
Anderson, S.D.2
Perry, C.P.3
Freed-Martens, R.4
Lassig, A.R.5
Charlton, B.6
-
4
-
-
37349077071
-
Radiolabelling of pharmaceutical aerosols & gamma scintigraphic imaging for lung deposition
-
Mercel Dekker, New York
-
Chan H.-K., Eberl S., and Glover W. Radiolabelling of pharmaceutical aerosols & gamma scintigraphic imaging for lung deposition. Encylcopedia of Pharmaceutical Technology (2006), Mercel Dekker, New York
-
(2006)
Encylcopedia of Pharmaceutical Technology
-
-
Chan, H.-K.1
Eberl, S.2
Glover, W.3
-
5
-
-
0034714871
-
Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders
-
Chew N.Y.K., Bagster D.F., and Chan H.K. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int. J. Pharm. 206 (2000) 75-83
-
(2000)
Int. J. Pharm.
, vol.206
, pp. 75-83
-
-
Chew, N.Y.K.1
Bagster, D.F.2
Chan, H.K.3
-
6
-
-
0032795651
-
Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols
-
Chew N.Y.K., and Chan H.-K. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols. Pharm. Res. 16 (1999) 1098-1103
-
(1999)
Pharm. Res.
, vol.16
, pp. 1098-1103
-
-
Chew, N.Y.K.1
Chan, H.-K.2
-
7
-
-
0036587705
-
Effect of powder polydispersity on aerosol generation
-
Chew N.Y.K., and Chan H.-K. Effect of powder polydispersity on aerosol generation. J. Pharm. Pharm. Sci. 5 (2002) 162-168
-
(2002)
J. Pharm. Pharm. Sci.
, vol.5
, pp. 162-168
-
-
Chew, N.Y.K.1
Chan, H.-K.2
-
8
-
-
1242323945
-
In vitro testing of pharmaceutical aerosols and predicting lung deposition from in vitro measurements
-
Bisgaard H., O'callaghan C., and Smalldone G.C. (Eds), Mercel Dekker, New York
-
Clark A., and Borgstrom L. In vitro testing of pharmaceutical aerosols and predicting lung deposition from in vitro measurements. In: Bisgaard H., O'callaghan C., and Smalldone G.C. (Eds). Drug Delivery to the Lung (2002), Mercel Dekker, New York
-
(2002)
Drug Delivery to the Lung
-
-
Clark, A.1
Borgstrom, L.2
-
9
-
-
0027228520
-
The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing
-
Clark A., and Hollingworth A. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing. J. Aerosol Med. 6 (1993) 99-110
-
(1993)
J. Aerosol Med.
, vol.6
, pp. 99-110
-
-
Clark, A.1
Hollingworth, A.2
-
10
-
-
24044542653
-
Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses
-
Coates M., Fletcher D., Chan H.K., and Raper J. Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses. Pharm. Res. 22 (2005) 1445-1453
-
(2005)
Pharm. Res.
, vol.22
, pp. 1445-1453
-
-
Coates, M.1
Fletcher, D.2
Chan, H.K.3
Raper, J.4
-
11
-
-
0031444391
-
Inhalation of dry-powder mannitol increases mucociliary clearance
-
Daviskas E., Anderson S.D., Brannan J.D., Eberl S., Chan H.K., and Bautovich G. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur. Respir. J. 10 (1997) 2449-2454
-
(1997)
Eur. Respir. J.
, vol.10
, pp. 2449-2454
-
-
Daviskas, E.1
Anderson, S.D.2
Brannan, J.D.3
Eberl, S.4
Chan, H.K.5
Bautovich, G.6
-
12
-
-
0033039551
-
Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchietasis
-
Daviskas E., Anderson S.D., Eberl S., Chan H.-K., and Bautovich G. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchietasis. Am. J. Respir. Crit. Care Med. 159 (1999) 1843-1848
-
(1999)
Am. J. Respir. Crit. Care Med.
, vol.159
, pp. 1843-1848
-
-
Daviskas, E.1
Anderson, S.D.2
Eberl, S.3
Chan, H.-K.4
Bautovich, G.5
-
13
-
-
0035110224
-
The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis
-
Daviskas E., Anderson S.D., Eberl S., Chan H.-K., and Young I. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest 119 (2001) 414-421
-
(2001)
Chest
, vol.119
, pp. 414-421
-
-
Daviskas, E.1
Anderson, S.D.2
Eberl, S.3
Chan, H.-K.4
Young, I.5
-
14
-
-
14844292681
-
Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis-Effect on lung function. Health status and sputum
-
Daviskas E., Anderson S.D., Gomes K., Briffa P., Cochrane B., Chan H.-K., and Bautovich G. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis-Effect on lung function. Health status and sputum. Respirology 10 (2005) 46-56
-
(2005)
Respirology
, vol.10
, pp. 46-56
-
-
Daviskas, E.1
Anderson, S.D.2
Gomes, K.3
Briffa, P.4
Cochrane, B.5
Chan, H.-K.6
Bautovich, G.7
-
15
-
-
0034886425
-
Aerosol deposition and clearance measurement: a novel technique using dynamic SPECT
-
Eberl S., Chan H.-K., Daviskas E., Constable C., and Young I.H. Aerosol deposition and clearance measurement: a novel technique using dynamic SPECT. Eur. J. Nucl. Med 28 (2001) 1365-1372
-
(2001)
Eur. J. Nucl. Med
, vol.28
, pp. 1365-1372
-
-
Eberl, S.1
Chan, H.-K.2
Daviskas, E.3
Constable, C.4
Young, I.H.5
-
16
-
-
0034278559
-
In vitro characterisation of metered-dose inhalers versus dry powder inhaler Glucocorticoid products: influence of inspiratory flow rates
-
Feddah M.R., Brown K.F., Gipps E.M., and Davies N.M. In vitro characterisation of metered-dose inhalers versus dry powder inhaler Glucocorticoid products: influence of inspiratory flow rates. J. Pharm. Pharm. Sci. 3 (2000) 317-324
-
(2000)
J. Pharm. Pharm. Sci.
, vol.3
, pp. 317-324
-
-
Feddah, M.R.1
Brown, K.F.2
Gipps, E.M.3
Davies, N.M.4
-
17
-
-
0030138949
-
Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodality imaging
-
Fleming J.S., Halson P., Conway J., Moore E., Nassim M.A., Hashish A.H., Bailey A.G., Holgate S.T., and Martonen T.B. Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodality imaging. J. Nucl. Med. 37 (1996) 873-877
-
(1996)
J. Nucl. Med.
, vol.37
, pp. 873-877
-
-
Fleming, J.S.1
Halson, P.2
Conway, J.3
Moore, E.4
Nassim, M.A.5
Hashish, A.H.6
Bailey, A.G.7
Holgate, S.T.8
Martonen, T.B.9
-
18
-
-
0029584118
-
Description of pulmonary deposition of radiolabeled aerosol by airway generation using a conceptional three dimensional model of lung morphology
-
Fleming J.S., Nassim M.A., Hashish A.H., Bailey A.G., Conway J., Holgate S., Halson P., Moore E., and Martonen T.B. Description of pulmonary deposition of radiolabeled aerosol by airway generation using a conceptional three dimensional model of lung morphology. J. Aerosol Med. 8 (1995) 341-356
-
(1995)
J. Aerosol Med.
, vol.8
, pp. 341-356
-
-
Fleming, J.S.1
Nassim, M.A.2
Hashish, A.H.3
Bailey, A.G.4
Conway, J.5
Holgate, S.6
Halson, P.7
Moore, E.8
Martonen, T.B.9
-
20
-
-
33846092239
-
Lung deposition of mannitol powder aerosol in healthy subjects
-
Glover W., Chan H.-K., Eberl S., Daviskas E., and Anderson S. Lung deposition of mannitol powder aerosol in healthy subjects. J. Aerosol Med. 19 (2006) 522-532
-
(2006)
J. Aerosol Med.
, vol.19
, pp. 522-532
-
-
Glover, W.1
Chan, H.-K.2
Eberl, S.3
Daviskas, E.4
Anderson, S.5
-
21
-
-
0028700063
-
Accerlerated image reconstruction using ordered subsets of projection data
-
Hudson H., and Larkin R. Accerlerated image reconstruction using ordered subsets of projection data. IEEE T. Med. Imaging 13 (1994) 601-609
-
(1994)
IEEE T. Med. Imaging
, vol.13
, pp. 601-609
-
-
Hudson, H.1
Larkin, R.2
-
22
-
-
3242666253
-
Aerosol dispersion of respirable particles in narrow size distributions produced by jet milling and spray drying techniques
-
Louey M., Van Oort M., and Hickey A. Aerosol dispersion of respirable particles in narrow size distributions produced by jet milling and spray drying techniques. Pharm. Res. 21 (2004) 1200-1206
-
(2004)
Pharm. Res.
, vol.21
, pp. 1200-1206
-
-
Louey, M.1
Van Oort, M.2
Hickey, A.3
-
23
-
-
25844435642
-
Studies of the human oropharyngeal airspaces using magnetic resonance imaging. III. The effects of device resistance with forced maneuver and tidal breathing on upper airway geometry
-
Mcrobbie D.W., and Pritchard S.E. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. III. The effects of device resistance with forced maneuver and tidal breathing on upper airway geometry. J. Aerosol Med. 18 (2005) 325-336
-
(2005)
J. Aerosol Med.
, vol.18
, pp. 325-336
-
-
Mcrobbie, D.W.1
Pritchard, S.E.2
-
24
-
-
1942533006
-
Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data
-
Meyer T., Brand P., Ehlich H., Kobrich R., Meyer G., Riedinger F., Sommerer K., Weuthen T., and Scheuch G. Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data. J. Aerosol Med. 17 (2004) 43-49
-
(2004)
J. Aerosol Med.
, vol.17
, pp. 43-49
-
-
Meyer, T.1
Brand, P.2
Ehlich, H.3
Kobrich, R.4
Meyer, G.5
Riedinger, F.6
Sommerer, K.7
Weuthen, T.8
Scheuch, G.9
-
25
-
-
0031804508
-
How well do in vitro particle size measurements predict drug delivery in vivo?
-
Newman S.P. How well do in vitro particle size measurements predict drug delivery in vivo?. J. Aerosol Med. 11 (1998) S97-S104
-
(1998)
J. Aerosol Med.
, vol.11
-
-
Newman, S.P.1
-
26
-
-
0028031785
-
Effect of different modes of inhalation on the drug delivery from a dry powder inhaler
-
Newman S.P., Hollingworth A., and Clark A.R. Effect of different modes of inhalation on the drug delivery from a dry powder inhaler. Int. J. Pharm. 102 (1994) 127-132
-
(1994)
Int. J. Pharm.
, vol.102
, pp. 127-132
-
-
Newman, S.P.1
Hollingworth, A.2
Clark, A.R.3
-
27
-
-
0000913821
-
Effect of inlet throat on the correlation between measured fine particle dose and lung deposition
-
Dalby R., Byron P., and Farr S. (Eds), Interpharm Press Inc.
-
Olsson B., Borgstrom L., Asking L., and Bondesson E. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. In: Dalby R., Byron P., and Farr S. (Eds). Respiratory Drug delivery V. (1996), Interpharm Press Inc.
-
(1996)
Respiratory Drug delivery V.
-
-
Olsson, B.1
Borgstrom, L.2
Asking, L.3
Bondesson, E.4
-
28
-
-
0033932666
-
Pulmonary drug delivery from the taifun dry powder inhaler is relatively independent of the patients inspiratory effort
-
Pitcairn G.R., Lanlinen T., Seppala O.-P., and Newman S.P. Pulmonary drug delivery from the taifun dry powder inhaler is relatively independent of the patients inspiratory effort. J. Aerosol Med. 13 (2000) 97-104
-
(2000)
J. Aerosol Med.
, vol.13
, pp. 97-104
-
-
Pitcairn, G.R.1
Lanlinen, T.2
Seppala, O.-P.3
Newman, S.P.4
-
29
-
-
0032834277
-
The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study
-
Robinson M., Daviskas E., Eberl S., Baker J., Chan H.-K., Anderson S.D., and Bye P.T. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur. Respir. J. 14 (1999) 678-685
-
(1999)
Eur. Respir. J.
, vol.14
, pp. 678-685
-
-
Robinson, M.1
Daviskas, E.2
Eberl, S.3
Baker, J.4
Chan, H.-K.5
Anderson, S.D.6
Bye, P.T.7
-
30
-
-
2942582581
-
Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhaler
-
Rohatagi S., Chapel S., Kirkesseli S., Newman S.P., Zhang J., Paccaly D., Randall L., Wray H., Wellington S., Shah B., and Jensen B.K. Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhaler. Am. J. Ther. 11 (2004) 103-113
-
(2004)
Am. J. Ther.
, vol.11
, pp. 103-113
-
-
Rohatagi, S.1
Chapel, S.2
Kirkesseli, S.3
Newman, S.P.4
Zhang, J.5
Paccaly, D.6
Randall, L.7
Wray, H.8
Wellington, S.9
Shah, B.10
Jensen, B.K.11
-
31
-
-
78649375457
-
-
Rowe R.C., Sheskey P.J., and Weller P.J. (Eds), Pharmaceutical Press, London
-
In: Rowe R.C., Sheskey P.J., and Weller P.J. (Eds). Pharmaceutical Excipients (2001), Pharmaceutical Press, London
-
(2001)
Pharmaceutical Excipients
-
-
-
32
-
-
0032496634
-
Lung deposition of budesonide in asthmatics: a comparison of different formulations
-
Thorsson L., Kenyon C., Newman S.P., and Borgstrom L. Lung deposition of budesonide in asthmatics: a comparison of different formulations. Int. J. Pharm. 168 (1998) 119-127
-
(1998)
Int. J. Pharm.
, vol.168
, pp. 119-127
-
-
Thorsson, L.1
Kenyon, C.2
Newman, S.P.3
Borgstrom, L.4
-
33
-
-
0028298466
-
The optimal particle size for b-adrenergic aerosols in mild asthmatics
-
Zanen P., Go L.T., and Lammers J.-W.J. The optimal particle size for b-adrenergic aerosols in mild asthmatics. Int. J. Pharm. 107 (1994) 211-217
-
(1994)
Int. J. Pharm.
, vol.107
, pp. 211-217
-
-
Zanen, P.1
Go, L.T.2
Lammers, J.-W.J.3
-
34
-
-
0028917783
-
The optimal particle size for parasympathicolytic aerosols in mild asthmatics
-
Zanen P., Go L.T., and Lammers J.-W.J. The optimal particle size for parasympathicolytic aerosols in mild asthmatics. Int. J. Pharm. 114 (1995) 111-115
-
(1995)
Int. J. Pharm.
, vol.114
, pp. 111-115
-
-
Zanen, P.1
Go, L.T.2
Lammers, J.-W.J.3
|